Toth Financial Advisory Corp Intellia Therapeutics, Inc. Transaction History

Toth Financial Advisory Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$33.3 - $44.82 $1,664 - $2,241	50 New	50 $1,000
Q4 2020 Jan 25, 2021	SELL	$18.83 - $63.53 $1,882 - $6,353	-100 Closed	0 $0
Q1 2020 Apr 20, 2020	BUY	$9.44 - $15.58 $944 - $1,558	100 New	100 $1,000
Q4 2019 Jan 27, 2020	SELL	$10.43 - $17.67 $1,460 - $2,473	-140 Closed	0 $0
Q2 2019 Jul 17, 2019	BUY	$13.88 - $18.41 $1,943 - $2,577	140 New	140 $2,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Toth Financial Advisory Corp with notifications on news.